Johnson & Johnson to request FDA authorization for vaccine booster shots

Drugmaker, Johnson & Johnson is planning to ask the U.S. regulator, Food and Drug Administration (FDA) to authorize a booster shot of its COVID-19 vaccine, according to officials familiar with the company’s plans.

This comes after drugmakers Pfizer and BioNTech commenced submission of data to the FDA for their authorisation of their COVID-19 vaccine for children of ages five to 11.

Last week, the FDA scheduled a meeting for October 15, 2021, for its expert advisory committee to determine whether to grant emergency use authorization for a booster shot of J&J’s vaccine.

Related posts

FG: 3,600,858 Eligible Nigerians have been vaccinated against Covid-19

Covid 19 update symptops

Why this matters

Recall that, the Biden administration in August announced the push for an extra dose as part of an effort to ensure protection against the latest Covid-19 variant, Delta variant. However, scientists are unable to agree over the need for booster shots in the United States, as scientists against the move cite reasons around the inaccessibility of the vaccines in other countries which leaves a larger part of their countries unvaccinated.

In the United States of America, according to the CDC, over 15 million Americans have been documented to receive the J&J’s vaccine, which is administered as a single dose.

Last month, Johnson & Johnson announced that an additional second shot of its vaccine given two months after the first shot increases its potency to 94%, compared with 70% effectiveness with the single shot.

Unlike J&J, the FDA has already authorized a booster dose of the Pfizer Inc and BioNTech vaccine for those 65 and older, including people who are highly at risk of severe diseases and people who are front-line workers or frequently exposed to the virus.

In addition, rival Moderna Inc also submitted its application seeking the FDA’s authorization for a booster shot of its two-dose vaccine last month and the regulator’s Advisory Committee panel is scheduled to hold a meeting on the 14th of October to discuss the feasibility of an additional dose.

Related

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
萌歌母の霊体験に梶裕貴絶句 thumbnail

萌歌母の霊体験に梶裕貴絶句

女優の上白石萌歌と声優の梶裕貴が26日、日本語版吹替声優を務めた映画『ゴーストバスターズ/アフターライフ』(2月4日公開)の公開前スペシャルイベントに出席した。ゴーストが登場する物語にちなんで自身の霊…
Read More
Index Of News
Total
0
Share